Androgen blockade and suppression for prostate carcinoma.
D000726:Androgen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D003534:Cyproterone / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005485:Flutamide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D048289:Imidazolidines; D008297:Male; D010906:Pituitary Hormone-Releasing Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000556:secondary
D000726:Androgen Antagonists; D007093:Imidazoles; D048289:Imidazolidines; D010906:Pituitary Hormone-Releasing Hormones; C021277:nilutamide; D005485:Flutamide; D003534:Cyproterone